Hmm, almost 2 years into the 5 year supply agreement. Marked as a material announcement yet no word on how the supply agreement is progressing since except for a few lines in their September 2017 quarterly stating "Revenues from Varm Cosmo and Lenis are expected to become material in 2018".
There was also one mention of them in the 2018 full year report stating that they were to distribute Cannepil throughout Europe.
Well we're in 2019 now, only a few more weeks before the end of the financial year, plenty of time to become a material revenue generator, right?
PS. LOL re: the Varm Cosmo mention
MXC Price at posting:
5.2¢ Sentiment: None Disclosure: Held
